Hesperetin-loaded lipid-core nanocapsules in polyamide: a new textile formulation for topical drug delivery
Authors:
- Paula dos Passos MenezesPMPaula dos Passos Menezes
- Luiza Abrahão FrankLuiza Abrahão Frank
- Yasmim CarvalhoYCYasmim Carvalho
- Mairim Russo SerafiniMSMairim Russo Serafini
- Lucindo José Quintans-JúniorLQLucindo José Quintans-Júnior
- Adriana Raffin PohlmannAPAdriana Raffin Pohlmann
- Sílvia Stanisçuaski GuterresSGSílvia Stanisçuaski Guterres
- Adriano Antunes de Souza AraújoAAAdriano Antunes de Souza Araújo
Open Access
- 1 March 2017
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 12, 2069-2079
Abstract
Chronic venous insufficiency is characterized by chronic reflux disorder of blood from the peripheral to the central vein, with subsequent venous hypertension and resulting changes in the skin. Traditionally, nonsurgical treatments relied on the use of compression therapy, and more recently a variety of flavonoids have been shown to have positive effects. There have also been developments of more effective drug delivery systems using various textiles and nanotechnology to provide new therapeutic options. Our objective was to use nanotechnology to develop a new formulation containing hesperetin (Hst), a substance not previously used in the treatment of chronic venous insufficiency, impregnated into textile fibers as a possible alternative treatment of venous diseases. We prepared the nanocapsules using the interfacial deposition of preformed polymer method with an Hst concentration of 0.5 mg/mL and then characterized the size and distribution of particles. To quantify the Hst in the samples, we developed an analytical method using high-performance liquid chromatography. Studies of encapsulation efficiency (98.81%±0.28%), microscopy, drug release (free-Hst: 104.96%±12.83%; lipid-core nanocapsule-Hst: 69.90%±1.33%), penetration/permeation, drug content (0.46±0.01 mg/mL) and the effect of washing the textile after drug impregnation were performed as part of the study. The results showed that nanoparticles of a suitable size and distribution with controlled release of the drug and penetration/permeation into the skin layers were achieved. Furthermore, it was established that polyamide was able to hold more of the drug, with a 2.54 times higher content than the cotton fiber; after one wash and after five washes, this relation was 2.80 times higher. In conclusion, this is a promising therapeutic alternative to be further studied in clinical trials.Keywords
This publication has 34 references indexed in Scilit:
- Hydrogel containing adapalene- and dapsone-loaded lipid-core nanocapsules for cutaneous application: development, characterization, in vitro irritation and permeation studiesDrug Development and Industrial Pharmacy, 2016
- Development of an Insect Repellent Spray for Textile Based on Permethrin-Loaded Lipid-Core NanocapsulesJournal of Nanoscience and Nanotechnology, 2016
- Evaluation of topical hesperetin matrix film for back-of-the-eye deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Physicochemical Characterization and Analgesic Effect of Inclusion Complexes of Essential Oil from Hyptis pectinata L. Poit Leaves with β-CyclodextrinCurrent Pharmaceutical Biotechnology, 2015
- Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental ModelsPhytotherapy Research, 2014
- Determination of In Vitro Usnic Acid Delivery into Porcine Skin Using a HPLC MethodJournal of Chromatographic Science, 2014
- Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug deliveryInternational Journal of Nanomedicine, 2014
- Nanosuspensions of hesperetin: preparation and characterization.2014
- Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in ratsNeurochemistry International, 2012
- Nanoparticle-based vaginal drug delivery systems for HIV preventionExpert Opinion on Drug Delivery, 2009